We have listened to the healthcare system and understood that doctors and hospitals need allies all along the patient pathway, not only in prevention but also in diagnosis, monitoring, and follow-up.

To align our purpose with this need, Previeni evolves and becomes


Born from the Italian words RILEvare (to detect) and MOnitorare (to monitor) while also recalling the detection of hemoglobin for clinicians, Rilemo embodies our mission:

Born from the Italian words RILEvare (to detect) and MOnitorare (to monitor) while also recalling the detection of hemoglobin for clinicians, Rilemo embodies our mission:

to be side-by-side with doctors to diagnose and monitor
fluid-related pathologies in Anyone, Anywhere.

to be side-by-side with doctors to diagnose and monitor fluid-related pathologies in
Anyone, Anywhere.

to be side-by-side with doctors to diagnose and monitor fluid-related pathologies in Anyone, Anywhere.

This website is intended for healthcare professionals and investors for informational purposes only and does not provide medical advice. Our products are in development and not yet approved by regulatory authorities, including the FDA (U.S.) and CE certification (EU MDR 2017/745). All product descriptions are based on early research. We are committed to meeting applicable standards, including ISO 13485, before release. For medical concerns, consult a licensed healthcare professional. Use of this website is at your own risk, and Rilemo s.r.l. disclaims any liability for reliance on the information provided.

© 2025 Rilemo s.r.l. All Rights Reserved

Rilemo s.r.l.
VAT: IT04187140134
REA: LC - 426250
Legal Address: Via Don Sebastiano Colleoni 20, Robbiate (LC), Italy
Capital: 10.000 €, Paid-in: 3.500 €© 2025 Rilemo s.r.l. All Rights Reserved

This website is intended for healthcare professionals and investors for informational purposes only and does not provide medical advice. Our products are in development and not yet approved by regulatory authorities, including the FDA (U.S.) and CE certification (EU MDR 2017/745). All product descriptions are based on early research. We are committed to meeting applicable standards, including ISO 13485, before release. For medical concerns, consult a licensed healthcare professional. Use of this website is at your own risk, and Rilemo s.r.l. disclaims any liability for reliance on the information provided.

© 2025 Rilemo s.r.l. All Rights Reserved

Rilemo s.r.l.
VAT: IT04187140134
REA: LC - 426250
Legal Address: Via Don Sebastiano Colleoni 20, Robbiate (LC), Italy
Capital: 10.000 €, Paid-in: 3.500 €

This website is intended for healthcare professionals and investors for informational purposes only and does not provide medical advice. Our products are in development and not yet approved by regulatory authorities, including the FDA (U.S.) and CE certification (EU MDR 2017/745). All product descriptions are based on early research. We are committed to meeting applicable standards, including ISO 13485, before release. For medical concerns, consult a licensed healthcare professional. Use of this website is at your own risk, and Rilemo s.r.l. disclaims any liability for reliance on the information provided.

© 2025 Rilemo s.r.l. All Rights Reserved

Rilemo s.r.l.
VAT: IT04187140134
REA: LC - 426250
Legal Address: Via Don Sebastiano Colleoni 20, Robbiate (LC), Italy
Capital: 10.000 €, Paid-in: 3.500 €